Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis
Authors
Keywords
-
Journal
International Journal of Rheumatic Diseases
Volume 20, Issue 6, Pages 722-730
Publisher
Wiley
Online
2016-12-10
DOI
10.1111/1756-185x.12959
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating cell-free DNA: A promising marker of regional lymphonode metastasis in breast cancer patients
- (2017) M. Agostini et al. Cancer Biomarkers
- Branched DNA-based Alu quantitative assay for cell-free plasma DNA levels in patients with sepsis or systemic inflammatory response syndrome
- (2016) Yan-Qiang Hou et al. JOURNAL OF CRITICAL CARE
- Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
- (2014) T B Hao et al. BRITISH JOURNAL OF CANCER
- Histone Deimination As a Response to Inflammatory Stimuli in Neutrophils
- (2014) I. Neeli et al. JOURNAL OF IMMUNOLOGY
- The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study
- (2013) Luca Quartuccio et al. ANNALS OF THE RHEUMATIC DISEASES
- High-Resolution Profiling of Fetal DNA Clearance from Maternal Plasma by Massively Parallel Sequencing
- (2013) S. C. Y. Yu et al. CLINICAL CHEMISTRY
- Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab
- (2012) A Ruyssen-Witrand et al. ANNALS OF THE RHEUMATIC DISEASES
- Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
- (2012) J E Gottenberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity
- (2012) M. J. Kaplan et al. JOURNAL OF IMMUNOLOGY
- Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital
- (2012) M. Couderc et al. ARTHRITIS CARE & RESEARCH
- Circulating tumour markers can define patients with normal colons, benign polyps and cancers
- (2011) R Mead et al. BRITISH JOURNAL OF CANCER
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating rheumatoid arthritis to target: recommendations of an international task force
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- Associations Between Tumor Necrosis Factor- (TNF- ) -308 and -238 G/A Polymorphisms and Shared Epitope Status and Responsiveness to TNF- Blockers in Rheumatoid Arthritis: A Metaanalysis Update
- (2010) Y. H. LEE et al. JOURNAL OF RHEUMATOLOGY
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
- (2008) C Potter et al. ANNALS OF THE RHEUMATIC DISEASES
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started